MedTrace Logo

Spartan COVID-19 System: Evaluation of Clinical Sample Collection

NCT04473248 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2020-11-13

No results posted yet for this study

Summary

This study will evaluate the efficacy of various sample collection methods for use with the Spartan COVID-19 System. It will compare the results from the Spartan COVID-19 System with results that are obtained using a predicate lab-based COVID-19 test that uses a nasopharyngeal swab sample. The goal is to determine which sample collection methods are most effective in capturing SARS-CoV-2 virus.

Conditions

  • Covid19

Interventions

DEVICE

Spartan COVID-19 System

PCR analysis of patient samples using the Spartan COVID-19 System

Sponsors & Collaborators

  • Humber River Hospital

    collaborator OTHER

  • The Ottawa Hospital

    collaborator OTHER

  • Spartan Bioscience Inc.

    lead INDUSTRY

Principal Investigators

  • Tara Linseman, MSc · Spartan Bioscience Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-28
Primary Completion
2020-08-30
Completion
2020-08-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04473248 on ClinicalTrials.gov